Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

AMP-303 safely increases hair growth in men with hair loss.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

The drug combination was safe and showed promise in treating advanced tumors.

Social media can help compare the effectiveness and safety of new arthritis medications.

5-ARI therapy may help prevent prostate cancer progression.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Cepharanthine shows promise as a COVID-19 treatment.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.